切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2012, Vol. 01 ›› Issue (01) : 1 -5. doi: 10.3877/cma.j.issn.2095-3224.2012.01.01

所属专题: 文献

述评

microRNAs在结直肠癌中的研究进展
杨宝峰1,()   
  1. 1. 150081 哈尔滨,哈尔滨医科大学药理学教研室 省部共建生物医药国家重点实验室 心血管药物研究教育部重点实验室
  • 收稿日期:2012-06-02 出版日期:2012-10-25
  • 通信作者: 杨宝峰
  • 基金资助:
    国家自然科学基金创新研究群体项目(81121003); 国家自然科学基金重点项目(81130088)

Research advances on microRNAs in colorectal cancer

Bao-feng YANG1,()   

  1. 1. Departmentof Pharmacology, State-province Key Laboratories of Biomedicine Pharmaceutics of China, Harbin Medical University, Harbin 150081, China
  • Received:2012-06-02 Published:2012-10-25
  • Corresponding author: Bao-feng YANG
  • About author:
    Corresponding author: YANG Bao-feng, Email:
引用本文:

杨宝峰. microRNAs在结直肠癌中的研究进展[J]. 中华结直肠疾病电子杂志, 2012, 01(01): 1-5.

Bao-feng YANG. Research advances on microRNAs in colorectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2012, 01(01): 1-5.

microRNAs(miRNAs)是一类长约22个核苷酸的内源性非编码RNA,通过与靶基因3’端非编码区结合,抑制靶miRNAs翻译或直接使其降解,参与调节多种生理和病理过程。近年来大量研究表明,miRNAs在结直肠癌发生与发展过程中扮演着促癌或抑癌基因的角色,可作为诊断标志物和治疗靶点。结直肠癌是一类高发病率和高死亡率的肠道肿瘤。本文对miRNAs在结直肠癌中的作用机制、诊断、治疗及耐药性等最新研究进展予以阐述。

MicroRNAs (miRNAs) are a class of endogenous, noncoding small RNAs, 22nt in length. Repressing the translation and inducing the degradation of target miRNAs genes by binding to the 3’-UTR participate in regulating multiple physiological and pathological processes. Many recent research implicates that miRNAs play oncogenic and tumor suppressor role in the initiation and progression of colorectal cancer. Thus, miRNAs are suggested as important markers in diagnosing and treating colorectal cancer. Colorectal cancer is one of intestinal tumor with high morbidity and mortality. This article reviews the recent research advances on molecular mechanism, diagnosis, treatment and drug resistance of miRNAs in colorectal cancer.

图1 调控结直肠癌十大特征的miRNAs
[1]
Jemal A,Siegel R,Xu J,Ward E, et al.Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5): 277-300.
[2]
Yang L,Parkin DM,Li L, et al.Time trends in cancer mortality in China:1987-1999[J]. Int J Cancer, 2003, 106(5): 771-783.
[3]
Inui M,Martello G,Piccolo S, et al.MicroRNA control of signal transduction[J]. Nat Rev Mol Cell Biol, 2010, 11(4): 252-263.
[4]
Lujambio A,Lowe SW.The microcosmos of cancer[J]. Nature, 2012, 482(7385): 347-355.
[5]
Hanahan D,Weinberg RA.Hallmarks of cancer:the next generation[J]. Cell, 2011, 144(5): 646-674.
[6]
Ruan K,Fang X,Ouyang G. MicroRNAs:novel regulators in the hallmarks of human cancer[J]. Cancer Lett, 2009, 285(2): 116-126.
[7]
Akao Y,Nakagawa Y,Naoe T. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells[J]. Biol Pharm Bull, 2006, 29(5): 903-906.
[8]
Chen X,Guo X,Zhang H, et al.Role of miR-143 targeting KRAS in colorectal tumorigenesis[J]. Oncogene, 2009, 28(10): 1385-1392.
[9]
Tazawa H,Tsuchiya N,Izumiya M, et al.Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells[J]. Proc Natl Acad Sci U S A, 2007, 04(39): 15472-15477.
[10]
Liu M,Lang N,Qiu M, et al.miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectalcancer cells[J]. Int J Cancer, 2011, 128(6): 1269-1279.
[11]
Sun JY,Huang Y,Li JP, et al.MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting beta-catenin[J]. Biochem Biophys Res Commun, 2012, 420(4): 787-792.
[12]
Baraniskin A,Birkenkamp-Demtroder K,Maghnouj A, et al.MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL[J]. Carcinogenesis, 2012, 33(4): 732-739.
[13]
Shi B,Sepp-Lorenzino L,Prisco M, et al.Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells[J]. J Biol Chem, 2007, 282(45): 32582-32590.
[14]
Luo H,Zou J,Dong Z, et al.Up-regulated miR-17 promotescell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma[J]. Biochem J, 2012, 442(2): 311-321.
[15]
Huang Z,Huang S,Wang Q, et al.MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma[J]. Cancer Res, 2011, 71(7): 2582-2589.
[16]
Nie J,Liu L,Zheng W, et al.MicroRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2[J]. Carcinogenesis, 2012, 33(1): 220-225.
[17]
Zhang H,Li Y,Huang Q, et al.MiR-148a promotes apoptosisby targeting Bcl-2 in colorectal cancer[J]. Cell Death Differ, 2011, 18(11): 1702-1710.
[18]
Nakano H,Miyazawa T,Kinoshita K, et al.Functional screening identifies a microRNA, miR-491 that induces apoptosis bytargeting Bcl-X(L)in colorectal cancer cells[J]. Int J Cancer, 2010, 127(5): 1072-1080.
[19]
Geng L,Zhu B,Dai BH, et al.A let-7/Fas double-negative feedback loop regulates human colon carcinoma cells sensitivity to Fas-related apoptosis[J]. Biochem Biophys Res Commun, 2011, 408(3): 494-499.
[20]
Ma YL,Zhang P,Wang F, et al.Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b[J]. J Cell Mol Med, 2011, 15(9): 1941-1954.
[21]
Grady WM,Parkin RK,Mitchell PS, et al.Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer[J]. Oncogene, 2008, 27(27): 3880-3888.
[22]
Chen ML,Liang LS,Wang XK.miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1[J]. Clin Exp Metastasis, 2012, 29(5): 457-469.
[23]
Wernicke AG,Shamis M,Sidhu KK, et al.Complication Rates in Patients With Negative Axillary Nodes 10 Years After Local Breast Radiotherapy After Either Sentinel Lymph Node Dissection or Axillary Clearance[J]. Am J Clin Oncol, 2011 Nov 29.[Epub ahead of print]
[24]
Liu X,Zhang Z,Sun L, et al.MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4[J]. Carcinogenesis, 2011, 32(12): 1798-1805.
[25]
Asangani IA,Rasheed SA,Nikolova DA, et al.MicroRNA-21(miR-21)post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer[J]. Oncogene, 2008, 27(15): 2128-2136.
[26]
Han HB,Gu J,Zuo HJ, et al.Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer[J]. J Pathol, 2012, 226(3): 544-555.
[27]
Arndt GM,Dossey L,Cullen LM, et al.Characterization ofglobal microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer[J]. BMC Cancer, 2009, 9: 374.
[28]
Sundaram P,Hultine S,Smith LM, et al.P53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers[J]. Cancer Res, 2011, 71(24): 7490-7501.
[29]
Fang JH,Zhou HC,Zeng C, et al.MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulat- ing matrix metalloproteinase 2 expression[J]. Hepatology, 2011, 54(5): 1729-1740.
[30]
Valeri N,Gasparini P,Fabbri M, et al.Modulation of mismatch repair and genomic stability by miR-155[J]. Proc Natl Acad Sci U SA, 2010 A, 107(15): 6982-6987.
[31]
Iliopoulos D,Jaeger SA,Hirsch HA, et al.STAT3 activation ofmiR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer[J]. Mol Cell, 2010, 39(4): 493-506.
[32]
Xu XT,Xu Q,Tong JL, et al.MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer[J]. Br J Cancer, 2012, 106(7): 1320-1330.
[33]
Kurokawa K,Tanahashi T,Iima T, et al.Role of miR-19b andits target mRNAs in 5-fluorouracil resistance in colon cancer cells[J]. J Gastroenterol, 2012 Mar 1.[Epub ahead of print]
[34]
Boni V,Bitarte N,Cristobal I, et al.miR-192/miR-215 influence5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation[J]. Mol Cancer Ther, 2010, 9(8): 2265-2275.
[35]
Liu K,Li G,Fan C, et al.Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer[J]. J Int Med Res, 2011, 39(6): 2288-2295.
[36]
Tong JL,Zhang CP,Nie F, et al.MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells[J]. FEBS Lett, 2011, 585(22): 3560-3568.
[37]
Ng EK,Chong WW,Jin H, et al.Differential expression of microRNAs in plasma of patients with colorectal cancer:a potential marker for colorectal cancer screening[J]. Gut, 2009, 58(10): 1375-1381.
[38]
Link A,Balaguer F,Shen Y, et al.Fecal MicroRNAs as novel biomarkers for colon cancer screening[J]. Cancer Epidemiol Biomarkers Prev, 2010, 19(7): 1766-1774.
[39]
Schetter AJ,Leung SY,Sohn JJ, et al.MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J]. JAMA, 2008, 299(4): 425-436.
[40]
Pichler M,Winter E,Stotz M, et al.Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer[J]. Br J Cancer, 2012, 106(11): 1826-1832.
[41]
Yamashita S,Yamamoto H,Mimori K, et al.MicroRNA-372 IsAssociated with Poor Prognosisin Colorectal Cancer[J]. Oncology, 2012, 82(4): 205-212.
[42]
[Nishida N,Yokobori T,Mimori K, et al.MicroRNA miR-125b is a prognostic marker in human colorectal cancer[J]. Int J Oncol, 2011, 38(5): 1437-1443.
[43]
Tsuchida A,Ohno S,Wu W, et al.miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer[J]. CancerSci, 2011, 102(12): 2264-2271.
[44]
Ibrahim AF,Weirauch U,Thomas M, et al.MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma[J]. Cancer Res, 2011, 71(15): 5214-5224.
[1] 应康, 杨璨莹, 刘凤珍, 陈丽丽, 刘燕娜. 左心室心肌应变对无症状重度主动脉瓣狭窄患者的预后评估价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 581-587.
[2] 张思平, 刘伟, 马鹏程. 全膝关节置换术后下肢轻度内翻对线对疗效的影响[J]. 中华关节外科杂志(电子版), 2023, 17(06): 808-817.
[3] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[4] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[5] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[6] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[7] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[8] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[9] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[10] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[11] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[12] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要